Parexel Announces Appointment of Rob Goodwin as Chief Operating Officer
Industry veteran brings proven expertise in global clinical development and further strengthens company focus on operational excellence, quality and deliveryRALEIGH,...
Clinical Trial
Parexel Announces Appointment of Rob Goodwin as Chief Operating Officer
Industry veteran brings proven expertise in global clinical development and further strengthens company focus on operational excellence, quality and deliveryRALEIGH,...
MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND
LA JOLLA, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND
LA JOLLA, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) today announced...
Spectral Medical Announces Publication of EDEN Observational Study
New Study Strengthens Rationale for Spectral’s PMX Therapy by Defining Endotoxic Septic Shock (ESS) as the Highest-Risk Patient GroupTORONTO, Sept....
Reunion Neuroscience Announces Final Closing of its Series A Financing and Plans to Advance RE104 into Clinical Development for the Treatment of Generalized Anxiety Disorder (GAD)
-- Upsized Series A Financing Brings Total Amount Raised to $133 Million -- -- GAD Affects 3.1% of U.S. Adult...
Annovis Reports Peer-Reviewed Publication Highlighting Pharmacokinetics of Novel Crystal Buntanetap
MALVERN, Pa., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical...
Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
First patient in South Korea dosedMIAMI, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the...
Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
Provides Patent Protection in Europe Through at Least December 2040 Further IP Protection for TNX-103 (Oral Levosimendan) and Other Drug...
Trially AI Seed Round Secures $4.7M and Launches “Margo” to Solve Clinical Trial Recruitment Bottleneck
AI-first platform transforms recruitment delays into instant enrollments by matching, engaging and enrolling patients in clinical trials.KANSAS CITY, Mo.--(BUSINESS WIRE)--Trially®,...
Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groupsClinical...
LabConnect and OmniScience to Deliver First Agentic AI Solution for Real-Time Clinical Trial Lab Insights
Together we're unlocking the true potential of clinical trial lab data, bringing faster insights, smarter decisions, and better outcomes. JOHNSON...
Next-Gen IRB Review Is Here: WCG ClinSphere™ eReview Manager Drives Transformative Efficiencies, Accelerates Clinical Research
CARY, N.C., Sept. 15, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical research,...
ProofPilot Acquires Lokavant to Transform Clinical Trial Performance with Predictive Analytics
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- ProofPilot, the leading end-to-end clinical experience platform, today announced the acquisition of Lokavant, the...
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
GAITHERSBURG, Md., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million...
Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease
Current XanaMIA pivotal phase 2/3 trial on track for interim analysis in January 2026 and final results late 2026 with...
Kerr Announces the Launch of SimpliCore(TM) Gutta Percha Carrier Obturators for Simplified Endodontics
BREA, CALIFORNIA / ACCESS Newswire / September 15, 2025 / Kerr is excited to announce the launch of SimpliCore™, a...
President Trump Clears the Path for Medical Marijuana Reform – Now Will DEA’s Terry Cole Act?
"By throwing out the DEA's Biden marijuana mess, President Trump opened the door for real medicine - MMJ's FDA cannabis...
Genflow Signs CDAs with Animal Health Companies
Genflow Signs CDAs with Animal Health Companies to Advance Longevity Gene Therapy Platform LONDON, UK / ACCESS Newswire / September...